The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000070.3(CAPN3):c.1469G>A (p.Arg490Gln)

CA341479

17622 (ClinVar)

Gene: CAPN3
Condition: autosomal recessive limb-girdle muscular dystrophy
Inheritance Mode: Autosomal recessive inheritance
UUID: d235fd78-cdd6-4aed-9d55-bc0a90ba72ce
Approved on: 2025-01-09
Published on: 2025-01-09

HGVS expressions

NM_000070.3:c.1469G>A
NM_000070.3(CAPN3):c.1469G>A (p.Arg490Gln)
NC_000015.10:g.42401755G>A
CM000677.2:g.42401755G>A
NC_000015.9:g.42693953G>A
CM000677.1:g.42693953G>A
NC_000015.8:g.40481245G>A
NG_008660.1:g.58653G>A
ENST00000349748.8:c.1325G>A
ENST00000357568.8:c.1469G>A
ENST00000397163.8:c.1469G>A
ENST00000466369.5:n.1978G>A
ENST00000483208.5:n.1700G>A
ENST00000495723.1:n.1700G>A
ENST00000549793.5:n.1700G>A
ENST00000638141.2:n.1340G>A
ENST00000673705.1:c.309+2103G>A
ENST00000318023.11:c.1325G>A
ENST00000349748.7:c.1325G>A
ENST00000357568.7:c.1469G>A
ENST00000397163.7:c.1469G>A
NM_000070.2:c.1469G>A
NM_024344.1:c.1469G>A
NM_173087.1:c.1325G>A
NM_024344.2:c.1469G>A
NM_173087.2:c.1325G>A
More

Pathogenic

Met criteria codes 4
PM3_Very Strong PM5 PP4 PP3
Not Met criteria codes 1
PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CAPN3 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_000070.3: c.1469G>A variant in CAPN3 is a missense variant predicted to cause substitution of arginine by glutamine at amino acid 490 (p.Arg440Gln). This variant has been detected in at least 16 individuals with limb girdle muscular dystrophy (PMID: 26404900, 18055493, 10330340, 22378277, 22443334, 18854869), including in a homozygous state in at least four cases (1.0 pt; PMID: 18055493, 10330340, 22443334) and confirmed in trans with a pathogenic variant in three cases (c.550del p.(Thr184ArgfsTer36), 3.0 pts, PMID: 26404900, 18854869, 22378277) (PM3_Very Strong). At least one patient with this variant displayed progressive limb girdle muscle weakness or a clinical suspicion of LGMD (PP4). The highest population minor allele frequency of this variant is 0.0001846 (3/16248 exome alleles) in the African/African American population in gnomAD v2.1.1, which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met). The computational predictor REVEL gives a score of 0.94, which is above the VCEP threshold of 0.70, evidence that correlates with impact to CAPN3 function (PP3). Another missense variant at the same codon, c.1468C>T p.(Arg490Trp), has been classified as pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PM3_Very Strong, PP4, PP3, PM5.
Met criteria codes
PM3_Very Strong
This variant has been detected in at least 16 individuals with limb girdle muscular dystrophy (PMID: 26404900, 18055493, 10330340, 22378277, 22443334, 18854869), including in a homozygous state in at least four cases (1.0 pt; PMID: 18055493, 10330340, 22443334) and confirmed in trans with a pathogenic variant in three cases (c.550del p.(Thr184ArgfsTer36), 3.0 pts, PMID: 26404900, 18854869, 22378277) (PM3_Very Strong).
PM5
Another missense variant at the same codon, c.1468C>T p.(Arg490Trp), has been classified as pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5).
PP4
At least one patient with this variant displayed progressive limb girdle muscle weakness or a clinical suspicion of LGMD (PP4).
PP3
The computational predictor REVEL gives a score of 0.94, which is above the VCEP threshold of 0.70, evidence that correlates with impact to CAPN3 function (PP3).
Not Met criteria codes
PM2
The highest population minor allele frequency of this variant is 0.0001846 (3/16248 exome alleles) in the African/African American population in gnomAD v2.1.1, which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.